Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy, safety and tolerability of 12-weeks
treatment with darifenacin in patients aged >Ý 65 years with OAB.